![]() All information provided herein is based on public and non-public information believed to be accurate and reliable, but is not necessarily complete and cannot be guaranteed. Any opinions expressed herein are subject to change without notice. ("Noble") and do not necessarily reflect statements or opinions expressed by any person or party affiliated with the company mentioned in this report. 18, 2022Īll statements or opinions contained herein that include the words "we", "us", or "our" are solely the responsibility of Noble Capital Markets, Inc. Readers should always contact their healthcare professionals for medical advice.ĭisclosures for Noble Capital Markets Inc., Stem Holdings Inc., Jan. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. ![]() As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Stem Holdings Inc., a company mentioned in this article.Ħ) This article does not constitute medical advice. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the decision to publish an article until three business days after the publication of the article. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.ĥ) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. This article is not a solicitation for investment. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.Ĥ) The article does not constitute investment advice. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.ģ) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. ![]() As of the date of this article, an affiliate of Streetwise Reports has a consulting relationship with Stem Holdings Inc. Click here for important disclosures about sponsor fees. She or members of her household are paid by the following companies mentioned in this article: None.Ģ) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. ![]() She or members of her household own securities of the following companies mentioned in the article: None. This situation also clouds Stem's future.ġ) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. Management indicated it may dispose of the ones in which it cannot obtain 100% ownership. Stem has ownership in other entities in more than a handful of other states, and it is unknown what will happen with all of those, Gomes pointed out. However, Stem's single location in California is a disadvantage when competing against operators with multiple sites in the state. Management is confident it can improve in those areas, but as Gomes noted, the "timing of such is unclear." Stem's newly obtained license to sell recreational cannabis in California should help sales (previously, it had only been selling medical marijuana in the state). The company plans to do just that this fiscal year, double down on those enterprises and on its grow businesses. "With the December 2021 divestiture of Driven Deliveries, we expect Stem to get back to its roots (i.e.,) its Oregon and California businesses," noted Gomes. Overall sales in Oregon have dropped to pre-COVID levels, and the California cannabis market is in crisis. He highlighted that the company's near-term future is clouded, in part by the cannabis environment in its key markets, Oregon and California. dba Driven By Stem (STEM:CSE STMH:OTCQX) more than doubled its FY20 revenue but still remains unprofitable, reported Noble Capital Markets analyst Joe Gomes. In fiscal year 2021 (FY21), Stem Holdings Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |